161 related articles for article (PubMed ID: 23499124)
21. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.
D'Angelillo RM; Sciuto R; Ramella S; Papalia R; Jereczek-Fossa BA; Trodella LE; Fiore M; Gallucci M; Maini CL; Trodella L
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):296-302. PubMed ID: 25084612
[TBL] [Abstract][Full Text] [Related]
22. [First experience of using positron emission tomography with 11C-choline in prostate cancer (PC)].
Granov AM; Tiutin LA; Ryzhkova DV; Shkol'nik MI; Andabekov TT; Mostova MI; Shatik SV; Kostenikov NA; Zaĭtsev VV; Tlostanova MS; Stanzhevskiĭ AA; Panfilenko AA; Arzumanov AA; Metelëv VV; Iliushchenko IuR
Vopr Onkol; 2013; 59(4):460-4. PubMed ID: 24032219
[TBL] [Abstract][Full Text] [Related]
23. [11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT.
Rybalov M; Breeuwsma AJ; Pruim J; Leliveld AM; Rosati S; Veltman NC; Dierckx RA; De Jong IJ
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):202-8. PubMed ID: 22402821
[TBL] [Abstract][Full Text] [Related]
24. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
[TBL] [Abstract][Full Text] [Related]
25. [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
Giovacchini G; Picchio M; Garcia-Parra R; Mapelli P; Briganti A; Montorsi F; Gianolli L; Messa C
J Urol; 2013 Jan; 189(1):105-10. PubMed ID: 23164385
[TBL] [Abstract][Full Text] [Related]
26. [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging.
Giovacchini G; Picchio M; Briganti A; Cozzarini C; Scattoni V; Salonia A; Landoni C; Gianolli L; Di Muzio N; Rigatti P; Montorsi F; Messa C
J Urol; 2010 Sep; 184(3):938-43. PubMed ID: 20643445
[TBL] [Abstract][Full Text] [Related]
27. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
Eur Urol; 2003 Jul; 44(1):32-8; discussion 38-9. PubMed ID: 12814672
[TBL] [Abstract][Full Text] [Related]
28. [ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF 11C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER].
Rybalov MA; De Iong IY; Breusma AI; Al'-Shukri SKh; Borovets SY
Vestn Khir Im I I Grek; 2015; 174(6):25-8. PubMed ID: 27066654
[TBL] [Abstract][Full Text] [Related]
29. ¹¹C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes.
Welle CL; Cullen EL; Peller PJ; Lowe VJ; Murphy RC; Johnson GB; Binkovitz LA
Radiographics; 2016; 36(1):279-92. PubMed ID: 26761541
[TBL] [Abstract][Full Text] [Related]
30. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
Mitchell CR; Lowe VJ; Rangel LJ; Hung JC; Kwon ED; Karnes RJ
J Urol; 2013 Apr; 189(4):1308-13. PubMed ID: 23123372
[TBL] [Abstract][Full Text] [Related]
31. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy.
Giovacchini G; Picchio M; Parra RG; Briganti A; Gianolli L; Montorsi F; Messa C
Clin Nucl Med; 2012 Apr; 37(4):325-31. PubMed ID: 22391699
[TBL] [Abstract][Full Text] [Related]
32. [18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: influence of antiandrogen therapy - a preliminary study.
Henninger B; Vesco P; Putzer D; Kendler D; Loizides A; Bale RJ; Virgolini IJ
Nucl Med Commun; 2012 Aug; 33(8):889-94. PubMed ID: 22692582
[TBL] [Abstract][Full Text] [Related]
33. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer.
von Eyben FE; Kairemo K
Nucl Med Commun; 2014 Mar; 35(3):221-30. PubMed ID: 24240194
[TBL] [Abstract][Full Text] [Related]
35. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
[TBL] [Abstract][Full Text] [Related]
36. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
37. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
[TBL] [Abstract][Full Text] [Related]
38. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.
Yoshida S; Nakagomi K; Goto S; Futatsubashi M; Torizuka T
Urol Int; 2005; 74(3):214-20. PubMed ID: 15812206
[TBL] [Abstract][Full Text] [Related]
39. The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide.
Murphy RC; Kawashima A; Peller PJ
AJR Am J Roentgenol; 2011 Jun; 196(6):1390-8. PubMed ID: 21606304
[TBL] [Abstract][Full Text] [Related]
40. Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer.
Garzon JG; Bassa P; Moragas M; Soler M; Riera E
Clin Nucl Med; 2014 Aug; 39(8):742-3. PubMed ID: 24978327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]